Palisade Bio (7NS0) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Pali-2108 | Ulcerative Colitis (Uc), Severe Ulcerative Colitis, Moderate Ulcerative Colitis | Phase II | Recruiting | A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis | Sep 21, 2026 | ― |
| Pali-2108 | Ulcerative Colitis (Uc), Healthy Volunteer | Phase I | Completed | Phase 1 Study Evaluating PALI-2108 in Healthy Volunteers and Ulcerative Colitis Patients. | Oct 25, 2024 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Pali-2108 | Phase II | Ulcerative Colitis (Uc), Severe Ulcerative Colitis, Moderate Ulcerative Colitis | Recruiting | A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis | Sep 21, 2026 | ― |
| Pali-2108 | Phase I | Ulcerative Colitis (Uc), Healthy Volunteer | Completed | Phase 1 Study Evaluating PALI-2108 in Healthy Volunteers and Ulcerative Colitis Patients. | Oct 25, 2024 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Palisade Bio, Inc. (DE:7NS0) have in its pipeline
Palisade Bio DE:7NS0 is currently developing the following drugs: Pali-2108. These drug candidates are in various stages of clinical development as the company works toward FDA approval.